282 related articles for article (PubMed ID: 19017592)
1. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.
Gartlehner G; Gaynes BN; Hansen RA; Thieda P; DeVeaugh-Geiss A; Krebs EE; Moore CG; Morgan L; Lohr KN
Ann Intern Med; 2008 Nov; 149(10):734-50. PubMed ID: 19017592
[TBL] [Abstract][Full Text] [Related]
2. Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians.
Qaseem A; Snow V; Denberg TD; Forciea MA; Owens DK;
Ann Intern Med; 2008 Nov; 149(10):725-33. PubMed ID: 19017591
[TBL] [Abstract][Full Text] [Related]
3. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.
Gartlehner G; Hansen RA; Morgan LC; Thaler K; Lux L; Van Noord M; Mager U; Thieda P; Gaynes BN; Wilkins T; Strobelberger M; Lloyd S; Reichenpfader U; Lohr KN
Ann Intern Med; 2011 Dec; 155(11):772-85. PubMed ID: 22147715
[TBL] [Abstract][Full Text] [Related]
4. Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.
Gartlehner G; Thieda P; Hansen RA; Gaynes BN; Deveaugh-Geiss A; Krebs EE; Lohr KN
Drug Saf; 2008; 31(10):851-65. PubMed ID: 18759509
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.
Hansen RA; Gartlehner G; Lohr KN; Gaynes BN; Carey TS
Ann Intern Med; 2005 Sep; 143(6):415-26. PubMed ID: 16172440
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.
Wagner G; Schultes MT; Titscher V; Teufer B; Klerings I; Gartlehner G
J Affect Disord; 2018 Mar; 228():1-12. PubMed ID: 29197738
[TBL] [Abstract][Full Text] [Related]
8. Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.
Reichenpfader U; Gartlehner G; Morgan LC; Greenblatt A; Nussbaumer B; Hansen RA; Van Noord M; Lux L; Gaynes BN
Drug Saf; 2014 Jan; 37(1):19-31. PubMed ID: 24338044
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis.
Nussbaumer B; Morgan LC; Reichenpfader U; Greenblatt A; Hansen RA; Van Noord M; Lux L; Gaynes BN; Gartlehner G
CNS Drugs; 2014 Aug; 28(8):699-712. PubMed ID: 24794101
[TBL] [Abstract][Full Text] [Related]
10. Second-generation antidepressants for preventing seasonal affective disorder in adults.
Gartlehner G; Nussbaumer B; Gaynes BN; Forneris CA; Morgan LC; Kaminski-Hartenthaler A; Greenblatt A; Wipplinger J; Lux LJ; Sonis JH; Hofmann J; Van Noord MG; Winkler D
Cochrane Database Syst Rev; 2015 Nov; (11):CD011268. PubMed ID: 26558418
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.
Thaler KJ; Morgan LC; Van Noord M; Gaynes BN; Hansen RA; Lux LJ; Krebs EE; Lohr KN; Gartlehner G
Depress Anxiety; 2012 Jun; 29(6):495-505. PubMed ID: 22553134
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
[TBL] [Abstract][Full Text] [Related]
13. The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis.
Gartlehner G; Thaler K; Hansen RA; Gaynes BN
Drug Saf; 2009; 32(12):1159-73. PubMed ID: 19916583
[TBL] [Abstract][Full Text] [Related]
14. Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians.
Gartlehner G; Gaynes BN; Amick HR; Asher GN; Morgan LC; Coker-Schwimmer E; Forneris C; Boland E; Lux LJ; Gaylord S; Bann C; Pierl CB; Lohr KN
Ann Intern Med; 2016 Mar; 164(5):331-41. PubMed ID: 26857743
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis.
Furukawa TA; Salanti G; Atkinson LZ; Leucht S; Ruhe HG; Turner EH; Chaimani A; Ogawa Y; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Suganuma A; Watanabe N; Stockton S; Geddes JR; Cipriani A
BMJ Open; 2016 Jul; 6(7):e010919. PubMed ID: 27401359
[TBL] [Abstract][Full Text] [Related]
16. [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani].
Gaillard R
Encephale; 2009 Oct; 35(5):499-504. PubMed ID: 19853726
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
